Mathias Klozenbücher joined FCF Fox Corporate Finance in June 2023. As Managing Director, he is responsible for the Life Sciences team and supports clients in the preparation, process management, and execution of transactions.

Prior to joining FCF, Mathias gained experience at Siemens Healthcare, leading M&A processes in New York and Berkeley. In addition to his experience at the corporate level, Mathias also served as Head of M&A for Speedinvest and as an independent advisor for Böhringer Ingelheim.

Mathias holds a Bachelor’s degree in Biology from the University of Vienna and a Master’s degree in Genetics from the University of California.